Lutetium Lu 177-Dotatate

 (loo-TEE-shee-um … DOH-tuh-tayt )

This page contains brief information about lutetium Lu 177-dotatate and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Lutathera
FDA Approved
Yes

FDA Approval for Lutetium Lu 177-Dotatate

Use in Cancer

Lutetium Lu 177-dotatate is approved to treat:

Lutetium Lu 177-dotatate is also being studied in the treatment of other types of cancer.

More About Lutetium Lu 177-Dotatate

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Research Results and Related Resources

Targeted Cancer Therapies

FDA Approves New Treatment for Certain Neuroendocrine Tumors

New Therapy Benefits Patients with Neuroendocrine Tumors

Clinical Trials Accepting Patients

Find Clinical Trials for Lutetium Lu 177-dotatate - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted: February 7, 2018
  • Updated: May 7, 2018